BeOne Medicines
ONC
#635
Rank
C$56.65 B
Marketcap
C$498.02
Share price
-3.82%
Change (1 day)
1.19%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Half-year Reports

Thumbnail BeOne Medicines Half-year Report 2025-h1

Half-year Report 2025-h1

Language: English

View Half-year Report